Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Gross Profit | -260 | 3,530 | 14,710 | 9,560 | 10,630 |
| Operating Expenses | 18,110 | 19,030 | 21,020 | 17,560 | 18,900 |
| Operating Income | -18,110 | -19,030 | -21,020 | -17,560 | -18,900 |
| Pre-tax Income | -18,110 | -19,030 | -21,020 | -17,560 | -18,900 |
| Net Income Continuous | -18,110 | -17,220 | -18,870 | -17,560 | -18,900 |
| Net Income | $-18,110 | $-17,220 | $-18,870 | $-17,560 | $-18,900 |
| EPS Diluted Before Non-Recurring Items | -1.21 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-13,740 | $-14,370 | $-16,840 | $-14,090 | $-15,880 |